coomassie brilliant blue has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Drummond, KJ; Kan, LK; Monif, M; O'Brien, TJ; Seneviratne, S; Williams, DA | 1 |
| Chen, J; Chen, X; Fang, J; Guo, G; Li, X; Liang, Y; Wang, L; Xiang, J; Zhang, B; Zhang, L; Zhang, W | 1 |
| Jantaratnotai, N; McGeer, PL; McLarnon, JG; Ryu, JK; Serrano-Perez, MC | 1 |
3 other study(ies) available for coomassie brilliant blue and Glioma
| Article | Year |
|---|---|
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Topics: Adamantane; Aminoquinolines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Microglia; Microscopy, Confocal; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Tumor Microenvironment | 2020 |
P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.
Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Indicators and Reagents; Male; Neovascularization, Pathologic; Purinergic P2X Receptor Antagonists; Radiography; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Vascular Endothelial Growth Factor A | 2013 |
Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Topics: Aged; Animals; Brain Neoplasms; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Glioma; Growth Inhibitors; Humans; Male; Middle Aged; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tumor Cells, Cultured | 2011 |